PhD, University of California, Los Angeles
MA, University of California, Los Angeles

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. J Clin Psychopharmacol. 2015 Feb; 35(1):34-42.View Related Profiles. PMID: 25427171; PMCID: PMC4276485; DOI: 10.1097/JCP.0000000000000246;.
  2. Frank DA, Kuranz S, Appugliese D, Cabral H, Chen C, Crooks D, Heeren T, Liebschutz J, Richardson M, Rose-Jacobs R. Problematic substance use in urban adolescents: role of intrauterine exposures to cocaine and marijuana and post-natal environment. Drug Alcohol Depend. 2014 Sep 1; 142:181-90.View Related Profiles. PMID: 24999059; PMCID: PMC4180288; DOI: 10.1016/j.drugalcdep.2014.06.014;.
  3. Rose-Jacobs R, Augustyn M, Beeghly M, Martin B, Cabral HJ, Heeren T, Richardson MA, Frank DA. Intrauterine substance exposures and Wechsler Individual Achievement Test-II scores at 11 years of age. Volnerable Children & Youth Studies. 2012; 7:186-197.
  4. Rose-Jacobs R, Soenksen S, Appugliese DP, Cabral HJ, Richardson MA, Beeghly M, Heeren TC, Frank DA. Early adolescent executive functioning, intrauterine exposures and own drug use. Neurotoxicol Teratol. 2011 May-Jun; 33(3):379-92.View Related Profiles. PMID: 21371553; PMCID: PMC3145371; DOI: 10.1016/;.
  5. Applebaum AJ, Otto MW, Richardson MA, Safren SA. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. J Clin Exp Neuropsychol. 2010 Jul; 32(6):579-89. PMID: 19890760; PMCID: PMC3638786; DOI: 10.1080/13803390903313572;.
  6. Knapp CM, Sarid-Segal O, Richardson MA, Colaneri LS, Afshar M, Devine E, Streeter CC, Piechniczek-Buczek J, Ciraulo DA. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):102-5.View Related Profiles. PMID: 20337506; DOI: 10.3109/00952991003674812;.
  7. Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care STDS. 2009 Jun; 23(6):455-62. PMID: 19519229; PMCID: PMC2856567; DOI: 10.1089/apc.2008.0181;.
  8. Sarid-Segal O, Knapp CM, Burch W, Richardson MA, Bahtia S, DeQuattro K, Afshar M, Richambault C, Sickels L, Devine E, Ciraulo DA. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. Am J Drug Alcohol Abuse. 2009; 35(5):316-9.View Related Profiles. PMID: 19637104; DOI: 10.1080/00952990903060150;.
  9. Applebaum AJ, Richardson MA, Brady SM, Brief DJ, Keane TM. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS Behav. 2009 Feb; 13(1):60-5.View Related Profiles. PMID: 18690532; DOI: 10.1007/s10461-008-9441-x;.
  10. Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM. Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care STDS. 2007 Dec; 21(12):942-55.View Related Profiles. PMID: 18154491.
Showing 10 of 22 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 4 distinct years, with a maximum of 2 publications in 1992 and 1997

Contact for Mentoring: